June 30, 2022
Femtech has a massive total addressable market across multiple billion-dollar industries such as (1) D2C and e-commerce, (2) digital health, (3) at-home test kits, and (4) employee health.
The rise of femtech has elevated equal access to healthcare and well-being for all. Women’s unique health issues are being addressed by companies like Allara Health which treats polycystic ovary syndrome (PCOS); Feminade for hormonal health, Maven Clinic for pregnancy care, and Carrot Fertility for fertility care.
Today, we’ll analyze top startups in femtech — how they are differentiated, how they tap into validated market needs & how builders & funders can capitalize on these market trends.
(1) VC funding in femtech is growing:
(2) Rise of femtech unicorns and top funding round:
(3) DTC femtech brands are becoming the target for acquisition:
(🔒 Full version) +6 more key trends in the Femtech space:
🔑 (4/9) New market segment that is gaining massive traction — what products do they offer? (3 company examples)
🔑 (5/9) How to build software that offers holistic wellness for women? (3 company examples)
🔑 (6/9) What new product offerings attract enterprise customers? (2 company examples)
🔑 (7/9) How women’s self-care apps are advancing to attract users? (2 company examples)
🔑 (8/9) New e-commerce categories that are attracting consumer interest. (6 company examples)
🔑 (9/9) How to apply the connected devices in the healthcare market? (4 company examples)
Find market niches, discover similar competitors, and explore ways to differentiate your new ideas:
(1) Severe shortage of medical professionals:
(2) Fertility treatment is expensive:
(🔒 Full version) +4 more well-defined market needs in the space:
🔑 (3/6) How to discover big market needs by understanding women’s biggest health issues? (2 company examples)
🔑 (4/6) What problems do existing players sucks at — and how can startups solve them 10x more effectively? (2 company examples)
🔑 (5/6) How to solve the maternal healthcare crisis through connected platform? (3 company examples)
🔑 (6/6) How to address underserved markets and which target audience to focus on? (3 company examples)
(1) Full-stack digital health model:
(🔒 Full version) 🔑 (2), (3), (4) +3 more business models implemented by market players
(1) D2C gynecological care:
(🔒 Full version) +6 more untapped market needs to leverage & capitalize:
🔑 (2/7) How can fertility care startups tap into new technology to deliver exceptional treatment success rates? (1 company example)
🔑 (3/7) How can e-commerce brands leverage the successful use cases in Femtech? (3 company examples)
🔑 (4/7) What emerging products are being developed that can tap into this $8 Billion dollar industry? (2 company examples)
🔑 (5/7) How to attract GenZ women, and consumers, by understanding their shifting needs? (3 product category examples)
🔑 (6/7) How to build the future of women’s healthcare for practitioners? (3 company examples)
🔑 (7/7) Which untapped market has a $533 Billion market size and constantly seeking new solutions in the Femtech space? (3 important use cases)
🔐 Full Version is Members-Only
2 new Full version trends report each month
2 new Market Map directories each month
Access 1,422+ company databases and expanding
Unlock 24 Pro reports past issues
No auto-renew. Re-subscribe anytime after expiration.
DISCLAIMER: All the content produced by the author(s) on this site (”Venturescale.to”) is not intended as, and shall not be construed as, financial advice. Please do your own research before making any material decisions related to any of the products or services described. Our content may contain links to third-party websites for information purposes and convenience only. Venturescale is not responsible for the success or authenticity of any project, we aim to act as a neutral informational resource for end-users. The Third-Party Sites are not under the control of Venturescale, therefore, we are not responsible for the content of any Third-Party Site, including without limitation any changes or updates to a Third-Party Site, and the inclusion of any link does not imply endorsement, approval or recommendation by Venturescale of the site or any association with its operators.